Pharmaceuticals Hong Kong

Hong Kong Burn Care Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Hong Kong Burn Care Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Product Type, By Depth of Burn, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Buy the full report

Report snapshot

Hong Kong Burn Care Market Analysis at a glance
Market size, 2025Researched figures come with the full report
Forecast, 2034Researched figures come with the full report
Growth (CAGR), 2025–2034Researched figures come with the full report
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct type, depth of burn and end user (see all)
Key playersSmith & Nephew, Molnlycke Health Care, Johnson & Johnson, ConvaTec Inc., 3M Company and 2 more (see all)
Regulator in Hong KongDrug OfficeSource: Drug Office, Department of Health. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

The Hong Kong Burn Care Market Analysis Executive Summary

Burns are injuries that happen to the body tissues as a result of heat, chemicals, electricity, radiation, and the sun. More than 400,000 people look for medical attention due to accidental burns annually in the United States. The first-degree burns and majority of the second-degree burn can be managed using home remedies. Third-degree burns are as dangerous as the third, and any misuse of the affected area can lead to death; therefore, it should be treated by specialists. Burn deaths have also increasingly been described in many high-income countries, and the current rate for child burn deaths in LMICs is above 7 times that of high-income countries. Patients receive morphine as well as anti-anxiety agents; the latter are typically administered when dressing changes are scheduled. When the patient is not going to a burn centre, the team might use topical agents which will also help in wound care, these include bacitracin and silver sulfadiazine (Silvadene) creams or ointments.

The burn care market is growing due to increasing cases of burns and development of new products including bioengineered skin substitutes and advanced dressings. While reimbursement schemes implemented by governments add affordability to costly treatments, high costs and scarcity of human cadres remain an issue. Inequalities in patients’ reimbursements also negatively impact their ability to access new and effective medical treatments. The COVID-19 outbreak affected burn care services, but the market recovered with a focus on updating standards for better practice and increasing access to enhanced care due to organizations such as ABA and WHO.

Hong Kong Burn Care Market Dynamics

Market Growth Drivers

The increase in burn incidence among patients worldwide, including those from LMICs, is another factor as it estimated causes 180,000 deaths per year. Due to this there have been high demand for skin grafts and various products for the management of burns which are effective in the overall management and healing. Development in technology is shifting towards innovative dressings and biological agents, which directly encourage the expansion of the novel products into the market due to the improved outcomes of the latter as a factor of the former. The trends in adoption of less invasive surgeries, combined with positive government policies and reimbursement practices are also driving the market. Secondly, the growth of the burn care market is due to the enhanced patient knowledge of available treatments for burn victims.

Opportunity

Burn market has tremendous potential in emerging economies like Asia, Latin America, and Africa as these countries have set higher growth rates in their healthcare budgets compared to developed nations, hence revealing a high demand for burns care products in countries like China, India, Brazil, and Mexico. Advancements in tissue engineering and regenerative medicine offer an even more useful application of skin grafts and their substitutes. Moreover, systematic advancements in the field such as smart wound dressings and bioactive dressing also show potential for better management of patient symptoms and enhanced healing time. With development of healthcare facilities and strengthening of the population’s consciousness, especially in the emergent states, the need for elaborate burn treatment options will emerge.

Market Restraints

The market for burn care is greatly influenced by factors such as the expensive products used in the treatment of burns that may act as restraints to the market. Lack of skilled human capital also presents a major challenge in terms of timely and adequate treatment of burn injuries, especially given that the COVID-19 pandemic impacted emergency response, as well as surgical and rehabilitation services. Also, differences in reimbursement policies reduce opportunities for infected patients to receive breakthrough treatments, which are even more challenges for recovery. The pandemic also affected the market through reduced admission for minor burn injuries and a decline in burn care surgeries.

Competitive Landscape Burn Care Market in Hong Kong

Key Players

Recent Developments

June 2024, Indian Army launches first-of-its-kind skin bank for treatment of severe burn injuries.

May 2025, FDA has approved three hydrogel dressings for diabetic wound care: Apligraf, Leucopatch, and Regranex.

March 2025, Convatec received FDA clearance for its device designed to manage complex surgical wounds and burns. InnovaBurn placental extracellular matrix medical device will serve as advanced ECM technology for partial-thickness, second-degree burns.

December 2022, MediWound received FDA clearance for its NexoBrid. It is used for the treatment of severe thermal burns in adults.

June 2021, FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns.

September 2021, Omeza Receives FDA Clearance for Omeza® Collagen Matrix. First Drug Device Combination of Its Kind for Chronic Wound Care.

Mergers and Acquisitions

March 2022, Essity Acquires Advanced Wound Care Company. Purchase of Hydrofera supports company's priority to grow through acquisitions in Medical Solutions.

Healthcare Policies and Regulatory Landscape for Burn Care Market in Hong Kong

Burn Care in Hong Kong: rules and payment

Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.⁠[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.⁠[2]

[1] Drug Office, Department of Health. Checked 14 Nov 2026.

[2] Hospital Authority. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Reimbursement schemes, where the government compensates for over 70% of the burn treatment costs, aids in the implementation of innovative therapies. Still, in equality of insurance coverage and reimbursement for providers hinders patient access to new therapies, such as advanced dressings and biologics. Professional bodies like the American Burn Association and the WHO are vital in lobbying for better reimbursement policies and increasing awareness of burn care. Affordability also continues to be a challenge to the adoption of approved treatment such as StrataGraft. The market is also witnessing the shift of focus towards technology progression to enhance the standard of healthcare facilities with the government’s backing. With the gradual easing of healthcare systems from the impact of COVID-19, there has been a renewed effort to improve burn care and reimbursement strategies.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Burn Care right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Burn Care in context

Hong Kong compared

  • People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 16 countries we cover in APAC.[1]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

What segments does the Burn Care market report cover?
The report splits the market by product type (Advanced Burn Care Products, Traditional Burn Care Products, Biologics, Other Burn Care Products), depth of burn (Minor Burns, Partial Thickness Burns, Full Thickness Burns) and end user (Hospitals, Physician Clinics, Home Care, Other End Users).
Who are the key players in the Burn Care market?
Key players include Smith & Nephew, Molnlycke Health Care, Johnson & Johnson, ConvaTec Inc., 3M Company and MediWound, among 7 companies the report profiles.
What is driving the Burn Care market?
The increase in burn incidence among patients worldwide, including those from LMICs, is another factor as it estimated causes 180,000 deaths per year. Due to this there have been high demand for skin grafts and various products for the management of burns which are effective in the overall management and healing.
Who regulates Burn Care in Hong Kong?
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health. Source: Drug Office, Department of Health. Checked 14 Nov 2026.
How is healthcare paid for in Hong Kong?
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government. Source: Hospital Authority. Checked 14 Nov 2026.
How much research is published on Burn Care?
PubMed lists 12,075 papers on Burn Care added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Hong Kong

See all

Related on wounds and burns and emergency and acute care

See the topic